glp 1 and anemia The promise peril of GLP-1 agonists: What we do (and don't) know as of August 2024 glp-1_ra_pharmacology [TUSOM | Pharmwiki]

Consumers taking GLP-1s are buying differently, cutting back on discretionary snacks while increasing purchases of protein, fibre and satiety-focused products

The decision to continue or discontinue Zepbound should weigh the benefits of weight loss against any mental health concerns, with patient safety and well-being as the primary consideration

Hex N, Bartlett C, Wright D, Taylor M, Varley D

Systematic reviews suggest that certain probiotic strains can modestly improve upper GI symptoms in functional dyspepsia compared with placebo, with good safety profiles overall.61 In IBS, multiple trials and reviews report small but meaningful reductions in abdominal pain, bloating, and stool irregularity for some patients, though results are strain-specific and not everyone responds.63 Spore-forming and Lactobacillus/Bifidobacterium strains are among the most studied

Once-weekly Insulin Ludefen demonstrated a favorable safety and tolerability profile, with no severe (level 3) hypoglycemic events occurring in the Insulin Ludefen group, while three severe (level 3) hypoglycemic events were reported in the insulin glargine U100 group

He practices at the Scheie Eye Institute